dystonia

(redirected from cervical dystonia)
Also found in: Dictionary, Medical.
Related to cervical dystonia: Cervical dysplasia

dystonia

[di′stōn·ē·ə]
(physiology)
Disorder or lack of muscle tonicity.
References in periodicals archive ?
is the 20th country to approve XEOMIN for the treatment of cervical dystonia and blepharospasm.
Cervical Dystonia (CD), also known as spasmodic torticollis, is a condition that primarily affects the muscles of the head and neck (the cervical area of the spine).
The approval includes two separate indications, the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain, and the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age.
NeuroBloc, known as MYOBLOC in the United States and Canada, was the first drug approved in the US to reduce the severity of abnormal head position and the neck pain associated with cervical dystonia.
for eight indications including cervical dystonia (involuntary distorsions of the neck).
Cervical Dystonia is a condition of abnormal muscle tone and movement that can result in painful abnormalities of posture or inability to flex and relax affected neck and shoulder muscles.
In cervical dystonia, the most common side effects following injection include difficulty swallowing (19%), upper respiratory infection (12%), neck pain (11%), and headache (11%).
The BLA submission relies on data from two pivotal Phase III studies performed in the United States and abroad totalling 252 patients followed-up for up to 12 treatment cycles, in addition to substantial patient exposure in other clinical studies in cervical dystonia.
investigational study of botulinum toxin type A for torticollis/ cervical dystonia.
With the help of patient advocates, "Make Your Mark" celebrates the inspirational stories of people living with blepharospasm or cervical dystonia (CD), also known as spasmodic torticollis, and aims to raise awareness of these often debilitating conditions.
Dysport([R]) is a neuromuscular blocking toxin which acts to block acetylcholine release, hence reducing muscular spasm, and was initially developed for the treatment of motor disorders and various forms of muscular spasticity, including cervical dystonia (a chronic condition in which the neck is twisted or deviated), spasticity of the lower limbs (heal) in children with cerebral palsy, blepharospasm (involuntary eye closure) and hemifacial spasm.
Data Indicate that XEOMIN, a Botulinum Toxin Type A Free From Accessory Proteins, Provides Sustained Efficacy For Up to 88 Weeks Among Both Toxin-Naive and Previously-Treated Cervical Dystonia Patients